Literature DB >> 24947600

The intrauterine device and the intrauterine system.

E Stephen Searle1.   

Abstract

Intrauterine contraception is used by about 100 million women worldwide, making it the most popular form of fertility regulation. In UK community contraception clinics, however, long-acting reversible contraception has increased to 28% of users, and intrauterine contraception accounts for only 8% of methods used by women accessing these services. Potential exists to increase uptake of these more effective methods. In this chapter, we review the clinical advantages, disadvantages and cost-effectiveness of intrauterine contraception. We discuss the management of complications along with advice for trainers, and briefly consider issues in developing countries.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  coil; contraception; effectiveness; intrauterine devise; intrauterine system; training

Mesh:

Year:  2014        PMID: 24947600     DOI: 10.1016/j.bpobgyn.2014.05.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  3 in total

1.  Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users.

Authors:  Matthew E Spotnitz; Karthik Natarajan; Patrick B Ryan; Carolyn L Westhoff
Journal:  Obstet Gynecol       Date:  2020-02       Impact factor: 7.623

2.  Contraception in chronic kidney disease: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology.

Authors:  Rossella Attini; Gianfranca Cabiddu; Benedetta Montersino; Linda Gammaro; Giuseppe Gernone; Gabriella Moroni; Domenico Santoro; Donatella Spotti; Bianca Masturzo; Isabella Bianca Gazzani; Guido Menato; Valentina Donvito; Anna Maria Paoletti; Giorgina Barbara Piccoli
Journal:  J Nephrol       Date:  2020-03-12       Impact factor: 3.902

3.  Intrauterine device found in an ovarian tumor: A case report.

Authors:  Yongyu An; Chang Liu; Fan Mao; Guangzhao Yang; Guoqun Mao
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.